BACKGROUND: The Renin-Angiotensin-Aldosterone-System plays a pivotal role in hypertension. Angiotensin II (Ang II) is a major regulator of aldosterone synthesis and secretion, and it is known to facilitate reactive oxygen species (ROS) generation in many cell types. AIMS: Here, we assessed the role of ROS signaling in Ang II-induced aldosterone synthesis by focusing on the regulation of aldosterone synthase (CYP11B2), a cytochrome P450 oxidase that catalyzes the final step in aldosterone biosynthetic pathway. RESULTS: Ang II increased CYP11B2 activity, mRNA and protein with a concomitant elevation of 6-Carboxy- 2',7'-dichlorodihydrofluorescein diacetate fluorescence, malondialdehyde and protein carbonyl levels (indices of ROS), NADPH oxidase (Nox) activity, and H(2)O(2) levels in human and rat adrenal cortical cells. The expression of nuclear receptor related 1 protein, a transcription factor known to regulate CYP11B2 expression, was also augmented by Ang II. These Ang II-evoked effects were either abolished or attenuated by pretreatment of cells with either Ang II type I receptor (AT(1)R) antagonist, or antioxidants or Nox inhibitor or siRNA silencing of Nox1, 2 and 4, or inhibitors of phospholipase C and protein kinase C. Exogenous H(2)O(2) mimicked the facilitatory effects of Ang II on CYP11B2 activity, mRNA, and protein expression, and these changes were significantly reduced by PEG-catalase. INNOVATION: ROS, particularly H(2)O(2), is identified as a key regulator of aldosterone production. CONCLUSION: Our results suggest that Ang II facilitates CYP11B2 activity and the ensuing aldosterone production via activation of AT(1)R-Nox-H(2)O(2) signaling pathway.
BACKGROUND: The Renin-Angiotensin-Aldosterone-System plays a pivotal role in hypertension. Angiotensin II (Ang II) is a major regulator of aldosterone synthesis and secretion, and it is known to facilitate reactive oxygen species (ROS) generation in many cell types. AIMS: Here, we assessed the role of ROS signaling in Ang II-induced aldosterone synthesis by focusing on the regulation of aldosterone synthase (CYP11B2), a cytochrome P450 oxidase that catalyzes the final step in aldosterone biosynthetic pathway. RESULTS:Ang II increased CYP11B2 activity, mRNA and protein with a concomitant elevation of 6-Carboxy- 2',7'-dichlorodihydrofluorescein diacetate fluorescence, malondialdehyde and protein carbonyl levels (indices of ROS), NADPH oxidase (Nox) activity, and H(2)O(2) levels in human and rat adrenal cortical cells. The expression of nuclear receptor related 1 protein, a transcription factor known to regulate CYP11B2 expression, was also augmented by Ang II. These Ang II-evoked effects were either abolished or attenuated by pretreatment of cells with either Ang II type I receptor (AT(1)R) antagonist, or antioxidants or Nox inhibitor or siRNA silencing of Nox1, 2 and 4, or inhibitors of phospholipase C and protein kinase C. Exogenous H(2)O(2) mimicked the facilitatory effects of Ang II on CYP11B2 activity, mRNA, and protein expression, and these changes were significantly reduced by PEG-catalase. INNOVATION: ROS, particularly H(2)O(2), is identified as a key regulator of aldosterone production. CONCLUSION: Our results suggest that Ang II facilitates CYP11B2 activity and the ensuing aldosterone production via activation of AT(1)R-Nox-H(2)O(2) signaling pathway.
Authors: Damian G Romero; Silvia Rilli; Maria W Plonczynski; Licy L Yanes; Ming Yi Zhou; Elise P Gomez-Sanchez; Celso E Gomez-Sanchez Journal: Physiol Genomics Date: 2007-02-27 Impact factor: 3.107
Authors: Sergey I Dikalov; Anna E Dikalova; Alfiya T Bikineyeva; Harald H H W Schmidt; David G Harrison; Kathy K Griendling Journal: Free Radic Biol Med Date: 2008-08-16 Impact factor: 7.376
Authors: Sabine Heumüller; Sven Wind; Eduardo Barbosa-Sicard; Harald H H W Schmidt; Rudi Busse; Katrin Schröder; Ralf P Brandes Journal: Hypertension Date: 2007-12-17 Impact factor: 10.190
Authors: Adam Whaley-Connell; Javad Habibi; Ravi Nistala; Melvin R Hayden; Lakshmi Pulakat; Catherine Sinak; Bonnie Locher; Carlos M Ferrario; James R Sowers Journal: Regul Pept Date: 2012-03-29
Authors: Saiful A Mir; Ying Li; Jacob D Story; Soma Bal; Linda Awdishu; Anneke A Street; Ravindra L Mehta; Prabhleen Singh; Sucheta M Vaingankar Journal: J Hypertens Date: 2018-05 Impact factor: 4.844
Authors: Rathi Prasad; Li F Chan; Claire R Hughes; Juan P Kaski; Julia C Kowalczyk; Martin O Savage; Catherine J Peters; Nisha Nathwani; Adrian J L Clark; Helen L Storr; Louise A Metherell Journal: J Clin Endocrinol Metab Date: 2014-03-06 Impact factor: 5.958